Top compounds associated with response to ENTPD6


Feature Type Standardized
Nominal ANOVA
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.13 0.0005
mRNA indisulam CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA parbendazole CTRPv2 pan-cancer AAC -0.11 0.0005
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA Irinotecan gCSI pan-cancer AAC -0.19 0.0006
mRNA VX-11e GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA Teniposide CTRPv2 pan-cancer AAC -0.14 0.0008
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
Download CSV